Bill > S2079

This bill, the Allergen Disclosure In Non-food Articles Act (ADINA Act), amends the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient that is, or is derived from, a major food allergen or a gluten-containing grain (such as wheat, barley, or rye). This labeling requirement will apply either on a date determined by the Secretary of Health and Human Services or two years after the bill's enactment, whichever is earlier. The purpose of this bill is to provide consumers with more information about the potential allergens in their medications.